Status:
RECRUITING
Clinical Evaluation of New Biomarkers for Ischemic Cerebrovascular Disease
Lead Sponsor:
Tongji Hospital
Conditions:
Ischemic Stroke
Ischemic Cerebrovascular Disease
Eligibility:
All Genders
18-90 years
Brief Summary
The goal of this single-center prospective observational study is to identify and evaluate new biomarkers for ischemic cerebrovascular disease (ICVD) to aid in early diagnosis, individualized treatmen...
Detailed Description
The detaited information about this trial is described below 1. Quality assurance: The research proposal is reviewed by an Independent Research Panel. If the proposal is approved, access to the study...
Eligibility Criteria
Inclusion
- Ischemic cerebrovascular disease has been proved by clinical symptoms and imaging examinations,including transient ischemic attack, cerebral ischemic stroke, steal syndrome, chronic cerebral hypoperfusion, ect al.
- sex and age-matched healthy individuals
Exclusion
- Brain CT or MRI showing cerebral hemorrhage (excluded ischemic stroke with hemorrhage transformation)
- With severe systemic disease, are expected to survive \< 3 months
- Patients will not able to provide continuous follow-up information
Key Trial Info
Start Date :
January 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2038
Estimated Enrollment :
7000 Patients enrolled
Trial Details
Trial ID
NCT06890702
Start Date
January 1 2025
End Date
January 1 2038
Last Update
December 9 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,
Wuhan, Hubei, China, 430030
2
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,
Wuhan, Hubei, China, 430030